The study analyzed treatment outcomes for hepatocellular carcinoma (HCC) related to newly established oncological resectability criteria. Results showed median survival times were 107.2 months for resectable (R) patients, 44.4 months for BR1, and only 18.4 months for BR2 patients. The data indicate that these criteria effectively stratify prognosis post-hepatectomy, with poor outcomes for BR2 patients suggesting the necessity for multidisciplinary treatment approaches.
Journal Article by Komatsu S, Yano Y (…) Fukumoto T et 7 al. in Ann Gastroenterol Surg
© 2024 The Author(s). Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.